FNDC8
geneOn this page
Also known as DKFZp434H2215
Summary
FNDC8 (fibronectin type III domain containing 8, HGNC:25286) is a protein-coding gene on chromosome 17q12, encoding Fibronectin type III domain-containing protein 8 (Q8TC99).
Located in nucleus.
Source: NCBI Gene 54752 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_017559
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25286 |
| Approved symbol | FNDC8 |
| Name | fibronectin type III domain containing 8 |
| Location | 17q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434H2215 |
| Ensembl gene | ENSG00000073598 |
| Ensembl biotype | protein_coding |
| Entrez | 54752 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000158009
RefSeq mRNA: 1 — MANE Select: NM_017559
NM_017559
CCDS: CCDS11290
Canonical transcript exons
ENST00000158009 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000714180 | 35127042 | 35127417 |
| ENSE00000714182 | 35129422 | 35129658 |
| ENSE00001160547 | 35130282 | 35130732 |
| ENSE00001160550 | 35121615 | 35121902 |
Expression profiles
Bgee: expression breadth broad, 56 present calls, max score 94.08.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2850 / max 298.6183, expressed in 4 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160336 | 0.2356 | 4 |
| 160334 | 0.0281 | 3 |
| 160335 | 0.0213 | 3 |
Top tissues by expression
212 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 94.08 | gold quality |
| right testis | UBERON:0004534 | 94.08 | gold quality |
| testis | UBERON:0000473 | 90.80 | gold quality |
| sperm | CL:0000019 | 85.02 | gold quality |
| male germ cell | CL:0000015 | 84.64 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.75 | gold quality |
| adult organism | UBERON:0007023 | 75.76 | gold quality |
| pancreatic ductal cell | CL:0002079 | 75.73 | silver quality |
| triceps brachii | UBERON:0001509 | 75.32 | gold quality |
| gluteal muscle | UBERON:0002000 | 73.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 72.48 | gold quality |
| olfactory bulb | UBERON:0002264 | 71.72 | gold quality |
| type B pancreatic cell | CL:0000169 | 71.61 | gold quality |
| quadriceps femoris | UBERON:0001377 | 71.57 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 71.55 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 71.01 | gold quality |
| diaphragm | UBERON:0001103 | 65.86 | gold quality |
| biceps brachii | UBERON:0001507 | 65.19 | gold quality |
| vena cava | UBERON:0004087 | 64.89 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 64.48 | gold quality |
| deltoid | UBERON:0001476 | 63.75 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 63.69 | gold quality |
| heart right ventricle | UBERON:0002080 | 62.74 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 62.03 | gold quality |
| thymus | UBERON:0002370 | 62.02 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 61.33 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 60.80 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 60.74 | gold quality |
| inferior olivary complex | UBERON:0002127 | 60.56 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 60.38 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31.21 |
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting FNDC8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-760 | 98.81 | 66.65 | 1392 |
| HSA-MIR-138-5P | 98.43 | 70.49 | 1292 |
| HSA-MIR-127-5P | 97.78 | 67.64 | 869 |
| HSA-MIR-296-5P | 97.61 | 64.02 | 851 |
| HSA-MIR-4456 | 97.50 | 64.88 | 1678 |
| HSA-MIR-4690-3P | 97.02 | 64.72 | 981 |
| HSA-MIR-5685 | 97.02 | 64.34 | 1004 |
| HSA-MIR-3126-5P | 96.87 | 65.83 | 912 |
| HSA-MIR-6875-5P | 96.87 | 65.49 | 958 |
| HSA-MIR-5194 | 96.77 | 63.91 | 1021 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fndc8 | ENSMUSG00000018844 |
| rattus_norvegicus | Fndc8 | ENSRNOG00000008264 |
Protein
Protein identifiers
Fibronectin type III domain-containing protein 8 — Q8TC99 (reviewed: Q8TC99)
All UniProt accessions (1): Q8TC99
RefSeq proteins (1): NP_060029* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003961 | FN3_dom | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036116 | FN3_sf | Homologous_superfamily |
Pfam: PF00041
UniProt features (4 total): sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TC99-F1 | 60.64 | 0.26 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 53 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, XU_GH1_AUTOCRINE_TARGETS_UP, CAGCTG_AP4_Q5, SCGGAAGY_ELK1_02, CACTGCC_MIR34A_MIR34C_MIR449, MIKKELSEN_MEF_LCP_WITH_H3K27ME3, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, ZWANG_DOWN_BY_2ND_EGF_PULSE, SRC_UP.V1_UP, KRAS.300_UP.V1_UP, KRAS.600_UP.V1_UP, KRAS.600.LUNG.BREAST_UP.V1_UP, KRAS.LUNG_UP.V1_UP, KRAS.LUNG.BREAST_UP.V1_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
130 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FNDC8 | SCP2D1 | Q9UJQ7 | 665 |
| FNDC8 | SYNGR4 | O95473 | 606 |
| FNDC8 | MGAT4D | A6NG13 | 598 |
| FNDC8 | GLB1L | Q6UWU2 | 576 |
| FNDC8 | FSCN3 | Q9NQT6 | 541 |
| FNDC8 | TMEM202 | A6NGA9 | 480 |
| FNDC8 | FAM221B | A6H8Z2 | 478 |
| FNDC8 | SLC36A3 | Q495N2 | 461 |
| FNDC8 | HMGB4 | Q8WW32 | 432 |
| FNDC8 | PRM1 | P04553 | 418 |
| FNDC8 | TEX13A | Q9BXU3 | 417 |
| FNDC8 | MAMLD1 | Q13495 | 399 |
| FNDC8 | USP26 | Q9BXU7 | 376 |
| FNDC8 | MORN3 | Q6PF18 | 369 |
| FNDC8 | BPIFA3 | Q9BQP9 | 355 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAD2L1BP | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SMCO1 | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FNDC8 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF76 | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FNDC8 | PIK3R3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FNDC8 | MCRS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FNDC8 | ZNF609 | psi-mi:“MI:0914”(association) | 0.350 |
| SPARCL1 | DUSP14 | psi-mi:“MI:0914”(association) | 0.350 |
| MAD2L1BP | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMCO1 | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FNDC8 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| ZNF76 | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PIK3R3 | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MCRS1 | FNDC8 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (19): FNDC8 (Two-hybrid), PIK3R3 (Two-hybrid), MAD2L1BP (Two-hybrid), MCRS1 (Two-hybrid), SMCO1 (Two-hybrid), MBLAC1 (Two-hybrid), KLHL24 (Affinity Capture-MS), LRP4 (Affinity Capture-MS), ZNF609 (Affinity Capture-MS), FNDC8 (Affinity Capture-MS), METTL18 (Affinity Capture-MS), SP3 (Affinity Capture-MS), EIF2AK2 (Affinity Capture-MS), DCP2 (Affinity Capture-MS), PTS (Affinity Capture-MS)
ESM2 similar proteins: A2CI98, A6NMN3, A7MBB4, B2RXB0, B4F6Q9, D3YV92, F1M5M3, F1MJR8, O43283, P15304, P56645, Q14CH0, Q1HKZ5, Q28F43, Q2KIP3, Q2NKQ1, Q2PFD7, Q2YDH8, Q3UPF5, Q3UZD7, Q3V1D5, Q4G017, Q4R767, Q5R7R7, Q5R8X7, Q5RA75, Q5RJN7, Q5SW75, Q61194, Q68FV5, Q6NRK3, Q6NXP2, Q6P995, Q75NT5, Q76I76, Q7M6U3, Q80TM9, Q8BPQ7, Q8BQU7, Q8CCC3
Diamond homologs: Q2YDH8, Q4R767, Q8TC99, Q9D2H8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
459 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:35121898:CTACT:C | donor_gain | 1.0000 |
| 17:35121900:ACT:A | donor_gain | 1.0000 |
| 17:35121903:G:GG | donor_gain | 1.0000 |
| 17:35127034:T:TA | acceptor_gain | 1.0000 |
| 17:35127037:TCCA:T | acceptor_loss | 1.0000 |
| 17:35127038:CCA:C | acceptor_loss | 1.0000 |
| 17:35127040:A:AG | acceptor_gain | 1.0000 |
| 17:35127040:AG:A | acceptor_gain | 1.0000 |
| 17:35127041:G:GG | acceptor_gain | 1.0000 |
| 17:35127041:GG:G | acceptor_gain | 1.0000 |
| 17:35127041:GGA:G | acceptor_gain | 1.0000 |
| 17:35127041:GGAA:G | acceptor_gain | 1.0000 |
| 17:35127413:C:G | donor_gain | 1.0000 |
| 17:35127415:GTG:G | donor_gain | 1.0000 |
| 17:35127415:GTGGT:G | donor_loss | 1.0000 |
| 17:35127416:TGGTG:T | donor_loss | 1.0000 |
| 17:35127417:GGT:G | donor_loss | 1.0000 |
| 17:35127418:G:GG | donor_gain | 1.0000 |
| 17:35127418:GTG:G | donor_loss | 1.0000 |
| 17:35127419:TGCG:T | donor_loss | 1.0000 |
| 17:35129569:C:G | donor_gain | 1.0000 |
| 17:35129575:GAGC:G | donor_gain | 1.0000 |
| 17:35129578:C:G | donor_gain | 1.0000 |
| 17:35129606:GT:G | donor_gain | 1.0000 |
| 17:35129659:G:GG | donor_gain | 1.0000 |
| 17:35130278:TCA:T | acceptor_loss | 1.0000 |
| 17:35130279:CAGT:C | acceptor_loss | 1.0000 |
| 17:35130280:A:AG | acceptor_gain | 1.0000 |
| 17:35130280:AGT:A | acceptor_loss | 1.0000 |
| 17:35130281:G:A | acceptor_loss | 1.0000 |
AlphaMissense
2126 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:35129428:T:A | W198R | 0.996 |
| 17:35129428:T:C | W198R | 0.996 |
| 17:35129612:G:C | R259P | 0.995 |
| 17:35127413:C:A | A194D | 0.993 |
| 17:35129609:T:A | V258D | 0.993 |
| 17:35129641:T:A | W269R | 0.993 |
| 17:35129641:T:C | W269R | 0.993 |
| 17:35130283:T:C | F275S | 0.992 |
| 17:35129430:G:C | W198C | 0.991 |
| 17:35129430:G:T | W198C | 0.991 |
| 17:35129643:G:C | W269C | 0.988 |
| 17:35129643:G:T | W269C | 0.988 |
| 17:35130282:T:C | F275L | 0.988 |
| 17:35130284:T:A | F275L | 0.988 |
| 17:35130284:T:G | F275L | 0.988 |
| 17:35129579:T:C | L248P | 0.987 |
| 17:35127412:G:C | A194P | 0.986 |
| 17:35129429:G:C | W198S | 0.986 |
| 17:35129570:T:C | L245P | 0.984 |
| 17:35129564:T:A | V243D | 0.983 |
| 17:35127377:C:A | P182H | 0.982 |
| 17:35129423:T:A | I196N | 0.981 |
| 17:35129464:T:G | Y210D | 0.981 |
| 17:35130283:T:G | F275C | 0.981 |
| 17:35129596:T:G | Y254D | 0.979 |
| 17:35129471:T:C | L212P | 0.978 |
| 17:35129635:G:T | G267W | 0.977 |
| 17:35129636:G:T | G267V | 0.977 |
| 17:35129423:T:G | I196S | 0.976 |
| 17:35129477:T:C | L214S | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000021705 (17:35123075 G>A), RS1000053048 (17:35122632 C>G), RS1000163855 (17:35130645 G>A), RS1000369254 (17:35124788 C>G,T), RS1000425693 (17:35130934 C>G,T), RS1000677557 (17:35123609 G>A), RS1001110921 (17:35123371 G>A), RS1001509744 (17:35128113 G>A), RS1002022743 (17:35127825 G>A), RS1002383568 (17:35121470 G>A), RS1002440909 (17:35128469 C>T), RS1002684549 (17:35120476 A>G), RS1003128646 (17:35120269 T>G), RS1003513514 (17:35125087 A>G), RS1004034235 (17:35124786 G>A)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:614291
GenCC curated gene-disease
Mondo (1): breast-ovarian cancer, familial, susceptibility to, 4 (MONDO:0013669)
Orphanet (1): Hereditary breast and/or ovarian cancer syndrome (Orphanet:145)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| N-(1-naphthyl)ethylenediamine | affects response to substance | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Urethane | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): breast-ovarian cancer, familial, susceptibility to, 4